306 related articles for article (PubMed ID: 17617181)
21. Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry.
Neofytos D; Horn D; Anaissie E; Steinbach W; Olyaei A; Fishman J; Pfaller M; Chang C; Webster K; Marr K
Clin Infect Dis; 2009 Feb; 48(3):265-73. PubMed ID: 19115967
[TBL] [Abstract][Full Text] [Related]
22. [Infections in solid organ transplant recipients].
Cuellar-Rodríguez J; Sierra-Madero JG
Rev Invest Clin; 2005; 57(2):368-80. PubMed ID: 16524080
[TBL] [Abstract][Full Text] [Related]
23. Approach to the Solid Organ Transplant Patient with Suspected Fungal Infection.
Anesi JA; Baddley JW
Infect Dis Clin North Am; 2016 Mar; 30(1):277-96. PubMed ID: 26739603
[TBL] [Abstract][Full Text] [Related]
24. High rate of invasive fungal infections following nonmyeloablative allogeneic transplantation.
Hagen EA; Stern H; Porter D; Duffy K; Foley K; Luger S; Schuster SJ; Stadtmauer EA; Schuster MG
Clin Infect Dis; 2003 Jan; 36(1):9-15. PubMed ID: 12491195
[TBL] [Abstract][Full Text] [Related]
25. [Guidelines for the treatment of invasive fungal disease by Aspergillus spp. and other fungi issued by the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC). 2011 Update].
Fortún J; Carratalá J; Gavaldá J; Lizasoain M; Salavert M; de la Cámara R; Borges M; Cervera C; Garnacho J; Lassaleta Á; Lumbreras C; Sanz MÁ; Ramos JT; Torre-Cisneros J; Aguado JM; Cuenca-Estrella M;
Enferm Infecc Microbiol Clin; 2011; 29(6):435-54. PubMed ID: 21474210
[TBL] [Abstract][Full Text] [Related]
26. Antifungal therapy strategies in hematopoietic stem-cell transplant recipients: early treatment options for improving outcomes.
Chandrasekar P; Ljungman PT
Transplantation; 2008 Jul; 86(2):183-91. PubMed ID: 18645475
[TBL] [Abstract][Full Text] [Related]
27. Antifungal prophylaxis in solid-organ transplant recipients: considerations for clinical trial design.
Singh N
Clin Infect Dis; 2004 Oct; 39 Suppl 4():S200-6. PubMed ID: 15546118
[TBL] [Abstract][Full Text] [Related]
28. [Usefulness of liposomal amphotericin B for the prophylaxis of fungal infection in solid organ transplant recipients].
López-Medrano F; Díaz-Pedroche C; Lumbreras C; Aguado JM
Rev Esp Quimioter; 2005 Mar; 18(1):14-20. PubMed ID: 15915227
[TBL] [Abstract][Full Text] [Related]
29. [Selected risk factors of fungal infections in human populations].
Kurnatowski P; Tyczkowska-Sieroń E
Wiad Parazytol; 2004; 50(3):367-72. PubMed ID: 16865939
[TBL] [Abstract][Full Text] [Related]
30. Recent advances and challenges in the treatment of invasive fungal infections.
Shao PL; Huang LM; Hsueh PR
Int J Antimicrob Agents; 2007 Dec; 30(6):487-95. PubMed ID: 17961990
[TBL] [Abstract][Full Text] [Related]
31. Zygomycosis in solid organ transplant recipients: a prospective, matched case-control study to assess risks for disease and outcome.
Singh N; Aguado JM; Bonatti H; Forrest G; Gupta KL; Safdar N; John GT; Pursell KJ; Muñoz P; Patel R; Fortun J; Martin-Davila P; Philippe B; Philit F; Tabah A; Terzi N; Chatelet V; Kusne S; Clark N; Blumberg E; Julia MB; Humar A; Houston S; Lass-Flörl C; Johnson L; Dubberke ER; Barron MA; Lortholary O
J Infect Dis; 2009 Sep; 200(6):1002-11. PubMed ID: 19659439
[TBL] [Abstract][Full Text] [Related]
32. Fungal infections after lung transplantation.
Solé A; Salavert M
Transplant Rev (Orlando); 2008 Apr; 22(2):89-104. PubMed ID: 18631862
[TBL] [Abstract][Full Text] [Related]
33. Risk factors for invasive fungal infections in haematopoietic stem cell transplantation.
Camps IR
Int J Antimicrob Agents; 2008 Nov; 32 Suppl 2():S119-23. PubMed ID: 19013335
[TBL] [Abstract][Full Text] [Related]
34. Evaluation and management of fungal infections in immunocompromised patients.
Venkatesan P; Perfect JR; Myers SA
Dermatol Ther; 2005; 18(1):44-57. PubMed ID: 15842612
[TBL] [Abstract][Full Text] [Related]
35. Trends in invasive disease due to Candida species following heart and lung transplantation.
Schaenman JM; Rosso F; Austin JM; Baron EJ; Gamberg P; Miller J; Oyer PE; Robbins RC; Montoya JG
Transpl Infect Dis; 2009 Apr; 11(2):112-21. PubMed ID: 19254327
[TBL] [Abstract][Full Text] [Related]
36. Viral and fungal infections after liver transplantation--part II.
Kusne S; Blair JE
Liver Transpl; 2006 Jan; 12(1):2-11. PubMed ID: 16382451
[TBL] [Abstract][Full Text] [Related]
37. Combination therapeutic approaches for the management of invasive aspergillosis in organ transplant recipients.
Singh N; Pursell KJ
Mycoses; 2008 Mar; 51(2):99-108. PubMed ID: 18254745
[TBL] [Abstract][Full Text] [Related]
38. Granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, and other immunomodulatory therapies for the treatment of infectious diseases in solid organ transplant recipients.
Page AV; Liles WC
Curr Opin Organ Transplant; 2008 Dec; 13(6):575-80. PubMed ID: 19060545
[TBL] [Abstract][Full Text] [Related]
39. Phaeohyphomycotic infections in solid organ transplant patients.
Garcia-Diaz JB; Baumgarten K
Semin Respir Infect; 2002 Dec; 17(4):303-9. PubMed ID: 12497547
[TBL] [Abstract][Full Text] [Related]
40. Efficiency and safety of inhaled amphotericin B lipid complex (Abelcet) in the prophylaxis of invasive fungal infections following lung transplantation.
Borro JM; Solé A; de la Torre M; Pastor A; Fernandez R; Saura A; Delgado M; Monte E; Gonzalez D
Transplant Proc; 2008 Nov; 40(9):3090-3. PubMed ID: 19010204
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
